Human

Human Prostate Gene DataBase
Name androgen-induced prostate proliferative shutoff associated protein
Symbol AS3
Aliases CG008; FLJ23236; KIAA0979
Gene Product
  • androgen-induced prostate proliferative shutoff associated protein
Category
  • Other in Prostate cancer
UniGeneHs.168625
OMIM605333
Locus23047
SummaryPutative regulator of androgen-induced proliferative prostate cell arrest; may interact with other proteins and bind DNA; contains leucine-zipper, DNA- and ATP-binding motifs
Gene Ontology
Expression
EST (98 ESTs, 62 libraries)
Tissue ? Frequency ? Count ?
blood (1/27)0.043 1/40686
bone marrow (1/263)1.000 1/38555
brain (4/204)0.005 7/362011
cervix (1/7)0.008 1/28115
colon (3/853)0.061 3/165626
embryo (2/19)0.004 3/37976
eye (2/33)0.010 4/93836
germ cell (1/7)0.001 1/57383
head and neck (4/990)0.186 4/79796
kidney (1/86)0.015 3/132968
liver (1/38)0.003 1/46472
lung (3/312)0.007 11/245386
muscle (1/21)0.013 3/71297
oral cavity (1/18)0.002 2/44567
ovary (3/144)0.016 4/81880
pancreas (3/33)0.002 4/117255
parathyroid (1/4)0.007 3/19377
placenta (4/342)0.002 5/157762
prostate (3/291)0.110 4/109871
skin (2/31)0.006 2/100815
spleen (1/7)0.009 1/9511
stomach (3/312)0.008 4/129930
testis (3/171)0.007 5/117531
uncharacterized tissue (11/1773)0.018 19/713325
uterus (2/212)0.682 2/155110
SAGE (8934147 tags, 162 libraries)
Tissue ? Frequency ? Count ?
brain (14/19)0.264 33/1658210
cerebellum (1/1)0.285 3/153840
colon (8/8)0.156 13/715217
eye (3/6)0.309 17/1250999
foreskin (1/2)1.000 1/9759
heart (1/1)0.096 3/168714
kidney (1/2)0.641 4/167428
lung (1/1)0.246 4/267429
mammary gland (10/19)0.367 33/1203512
ovary (9/10)0.727 14/324994
pancreas (5/8)0.124 5/165497
prostate (10/13)0.252 18/761270
skin (1/7)0.109 1/22466
stomach (3/3)0.210 7/439098
uncharacterized tissue (15/22)0.305 35/1491542
vascular (2/3)0.074 2/134172
SNPrs614770 (T/G:intron);  rs597860 (C/T:intron);  rs2150919 (T/A:intron);  rs1029304 (G/T:intron);  rs634119 (C/T:intron);  rs2209324 (A/G:intron);  rs2147350 (T/A:mrna-utr);  rs1144532 (A/G:mrna-utr);  rs2224883 (A/G:intron);  rs1148326 (A/C:mrna-utr);  rs2301388 (A/G:coding-nonsyn);  rs733487 (A/G:intron);  rs513329 (C/T:intron);  rs687416 (C/T:intron);  rs1929937 (C/T:intron);  rs1015328 (C/G:intron);  rs503116 (G/A:intron);  rs650852 (A/G:intron);  rs3135187 (A/T:intron);  rs208422 (A/G:mrna-utr);  rs382191 (C/G:mrna-utr);  rs658996 (C/T:intron);  rs1018800 (A/T:mrna-utr);  rs498372 (C/A:intron);  rs2021658 (C/T:mrna-utr);  rs540942 (T/G:mrna-utr);  rs962454 (A/C:intron);  rs2213377 (T/G:intron);  rs731413 (G/T:mrna-utr);  rs498745 (A/C:intron);  rs2051570 (A/G:intron);  rs506645 (G/A:intron);  rs590383 (C/T:intron);  rs646756 (A/G:intron);  rs573014 (C/T:intron);  rs969703 (A/G:intron);  rs3119702 (A/G:intron);  rs129480 (C/G:locus-region);  rs408711 (C/T:mrna-utr);  rs442758 (A/T:mrna-utr);  rs729891 (C/T:intron);  rs638991 (G/A:intron);  rs590558 (G/A:intron);  rs2320236 (G/T:mrna-utr);  rs513059 (C/T:intron);  rs2032495 (G/T:mrna-utr);  rs3050179 (GTGT/-:intron);  rs208429 (C/T:mrna-utr);  rs1924606 (A/G:intron);  rs399622 (G/T:mrna-utr);  rs1324414 (A/G:mrna-utr);  rs797994 (C/T:mrna-utr);  rs2320468 (G/T:intron);  rs3492 (A/C:mrna-utr);  rs2183873 (T/G:mrna-utr);  rs743845 (C/G:mrna-utr);  rs473672 (G/A:intron);  rs208409 (C/T:mrna-utr);  rs2874281 (A/G:intron);  rs409010 (C/T:mrna-utr);  rs561056 (C/T:intron);  rs1207709 (A/G:mrna-utr);  rs677095 (G/A:mrna-utr);  rs2031354 (A/T:mrna-utr);  rs762900 (A/G:intron);  
EvidenceOther in Prostate cancer
© 2002, PGDB, All Rights Reserved.
Department of Urology
Universityof California, San Francisco